Skip to main content

Table 4 Gene set variation analysis of upregulated and downregulated gene sets in the cetuximab resistant group

From: Identification of key genes involved in tumor immune cell infiltration and cetuximab resistance in colorectal cancer

HALLMARK GENE SETS

Log [FC]

p value

Adjustive p value

HALLMARK_MYOGENESIS

1.058

2.34Eāˆ’05

3.89Eāˆ’04

HALLMARK_INTERFERON_ALPHA_RESPONSE

1.115

3.21Eāˆ’05

3.89Eāˆ’04

HALLMARK_MYC_TARGETS_V1

āˆ’1.096

3.89Eāˆ’05

3.89Eāˆ’04

HALLMARK_MYC_TARGETS_V2

āˆ’1.134

2.88Eāˆ’05

3.89Eāˆ’04

HALLMARK_ANGIOGENESIS

1.229

1.43Eāˆ’05

3.89Eāˆ’04

HALLMARK_TGF_BETA_SIGNALING

1.078

9.87Eāˆ’05

6.17Eāˆ’04

HALLMARK_INTERFERON_GAMMA_RESPONSE

0.909

9.74Eāˆ’05

6.17Eāˆ’04

HALLMARK_UNFOLDED_PROTEIN_RESPONSE

āˆ’0.978

7.86Eāˆ’05

6.17Eāˆ’04

HALLMARK_E2F_TARGETS

āˆ’0.915

2.91Eāˆ’04

1.45Eāˆ’03

HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION

0.741

2.72Eāˆ’04

1.45Eāˆ’03

HALLMARK_APICAL_JUNCTION

0.820

3.21Eāˆ’04

1.46Eāˆ’03

HALLMARK_G2M_CHECKPOINT

āˆ’0.926

7.41Eāˆ’04

3.09Eāˆ’03

HALLMARK_APOPTOSIS

0.574

1.13Eāˆ’03

4.13Eāˆ’03

HALLMARK_HEME_METABOLISM

0.610

1.16Eāˆ’03

4.13Eāˆ’03

HALLMARK_KRAS_SIGNALING_UP

āˆ’0.622

1.24Eāˆ’03

4.13Eāˆ’03

HALLMARK_ESTROGEN_RESPONSE_EARLY

0.572

1.41Eāˆ’03

4.16Eāˆ’03

HALLMARK_PEROXISOME

0.676

1.38Eāˆ’03

4.16Eāˆ’03

HALLMARK_UV_RESPONSE_DN

0.624

1.95Eāˆ’03

5.42Eāˆ’03

HALLMARK_HEDGEHOG_SIGNALING

0.742

1.96Eāˆ’02

4.97Eāˆ’02

HALLMARK_OXIDATIVE_PHOSPHORYLATION

āˆ’0.599

2.09Eāˆ’02

4.97Eāˆ’02

HALLMARK_REACTIVE_OXYGEN_SPECIES_PATHWAY

0.706

2.03Eāˆ’02

4.97Eāˆ’02